Besides plain old borning cash, now would be an
excellent time for Genzyme to buy some cheap
technology and assign it to Gizzmo.
Hmmm, what would they do, issue some GENZ or
issue some GZMO to pay for the purchase. We
need to seem some M&A!
Thanks for the thing about the MGED group,
I don't yet know what the heck I'm looking at yet.
For authors, the proposal provides a checklist
of variables that should be included in every microarray
publication, at
mged.org
This checklist, with all variables completed, would be supplied as supplementary information at the time of submission.
nature.com
Something fun to muddle through tonight.
I own 10,000 GZMO at $1.80
ooof! I have a bunch of biotech symbols on the
back of an envelope for my broker. With most
down there with prices that make them look
like penny stocks and delisting candidates, he
is going to balk at buying anything. And then
I am going to fire him and transfer my dry powder
into treasuries. Now that is sad.
Enjoyed the pictures of climbing and desert flowers! |
